Every Form 4 that AYRO, Inc. (AYRO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AYRO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AYRO filings page.
StableX Technologies, Inc. (SBLX) reported an insider equity award. CEO and Director Joshua Silverman filed a Form 4 disclosing an employee stock option grant to purchase 220,513 shares of common stock at an exercise price of $6.25 per share on 10/31/2025. The filing lists the option grant price as $0.
Vesting terms: 75% vested on the grant date; the remaining 25% is scheduled to vest on December 31, 2025, contingent on continued service. Following the transaction, Silverman directly beneficially owns 220,513 derivative securities.
StableX Technologies (SBLX) reported an insider equity award. A director received 22,723 employee stock options on 10/31/2025 at a $6.25 exercise price. 75% vested at grant and the remaining 25% will vest on December 31, 2025, conditioned on continued service. The options expire on 10/31/2035. After this transaction, the reporting person beneficially owned 22,723 derivative securities, held directly.
StableX Technologies (SBLX) reported a director compensation grant on a Form 4. On 10/31/2025, the reporting person received an employee stock option to purchase 22,723 shares of common stock at an exercise price of $6.25 per share, expiring on 10/31/2035. The option was reported as Direct (D) ownership with an acquisition price of $0.
The vesting schedule states that 75% vested upon grant, and the remaining 25% will vest on December 31, 2025, contingent on continued service to the company. This filing reflects an equity award rather than a sale of shares.
StableX Technologies, Inc. (SBLX) reported an insider equity award on a Form 4. Director Greg Schiffman received an employee stock option to purchase 22,723 shares of common stock at an exercise price of $6.25 per share on 10/31/2025. The option expires on 10/31/2035.
Vesting is split: 75% vested on the grant date, and the remaining 25% will vest on December 31, 2025, conditioned on continued service with the company. Following the reported transaction, the filing shows 22,723 derivative securities beneficially owned, held directly.
StableX Technologies, Inc. (SBLX) director Wayne Walker reported an option grant. On 10/31/2025, he received 22,723 employee stock options with a $6.25 exercise price.
The grant vests 75% at the date of grant and 25% on December 31, 2025, provided he continues to provide services to the company on that date. Following the transaction, 22,723 derivative securities were beneficially owned on a direct basis.